Brisbane, Australia       Tue, 23 Nov 2021 at 6:00 pm AEST

Sydney/Melbourne, Australia      Tue, 23 Nov 2021 at 7:00 pm AEDT     
Auckland, New Zealand     Tue, 23 Nov 2021 at 9:00 pm NZDT    
Kuala Lumpur, Malaysia    Tue, 23 Nov 2021 at 4:00 pm MYT     
Jakarta, Indonesia        Tue, 23 Nov 2021 at 3:00 pm WIB     
Brussels, Belgium         Tue, 23 Nov 2021 at 9:00 am CET     


6.00pm AEST   Welcome and introductions
Professor Jason Roberts, The University of Queensland CRE REDUCE, Brisbane
Co-chair: Dr Holly Sinclair, Senior Registrar in Infectious Disease and Microbiology, The Prince Charles Hospital
Co-chair: Dr Alice Sawka, Mycobacterial Fellow, Princess Alexandra Hospital


6.05pm AEST   Determination of tuberculosis susceptibility using molecular techniques 
Associate Professor Chis Coulter,  Director, Queensland Mycobacterium Reference Laboratory


6.30pm AEST   Case studies in tuberculosis and therapeutic drug monitoring (TDM) 
Dr Andrew Burke, Infectious Disease and Thoracic Physician, The Prince Charles Hospital


6.55pm AEST   Could TDM improve tuberculosis treatment outcomes? Designing TDM trials in real-world settings
Professor Johannes (Jan-Willem) Alffenaar, Chair of Clinical Pharmacy, University of Sydney


7.20pm AEST    Q&A

Thank you for watching!



About Antimicrobial Optimisation Webinar series

Infections in the healthcare setting are common and cause too many people to die. Severe infections commonly occur in patients with critical illness, burns, transplant, cystic fibrosis and immunosuppression. Infections in these patients are more difficult to treat, leading to multi-drug resistant (‘superbug’) infections associated with increased mortality and poorer health outcomes.

This Antimicrobial Optimisation workshop will convey the principles of susceptibility testing for antibacterial, antifungal, viral and antimycobacterials. Expert practitioners will describe the principles of drug dosing in different patient populations and clarify the role of therapeutic drug monitoring. The format of the workshop will be four, 20-minute presentations followed by opportunities for questions and answers.

Learning objectives of the Antimicrobial Optimisation Webinar series:

  • Principles of susceptibility testing for antibacterial, antifungal, viral and antimycobacterials
  • Pharmacokinetic considerations in special patient populations
  • Principles of drug dosing in different patient populations
  • Role of therapeutic drug monitoring
  • Therapeutics for invasive fungal infections and antifungal drugs

Thank you to our program sponsors:




Other upcoming sessions